Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael S. Gordon, MD
Virginia G. Piper Cancer Center at Scottsdale Healthcare - Shea
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Westmead Hospital
Westmead, New South Wales, Australia
- Instituto de Enfermedades Neoplasicas
Lima, Peru
- San Juan City Hospital
San Juan, Puerto Rico
- Ccop - Mayo Clinic Scottsdale Oncology Program
Scottsdale, Arizona, United States
- Ccop - Northern Indiana Cr Consortium
South Bend, Indiana, United States
- Iowa Lutheran Hospital
Des Moines, Iowa, United States
- John Stoddard Cancer Center at Iowa Methodist Medical Center
Des Moines, Iowa, United States
- Mercy Cancer Center at Mercy Medical Center-Des Moines
Des Moines, Iowa, United States
- Midlands Cancer Center at Midlands Community Hospital
Papillion, Nebraska, United States
- Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Mbccop - University of New Mexico Hsc
Albuquerque, New Mexico, United States
- Comprehensive Cancer Center at Our Lady of Mercy Medical Center
The Bronx, New York, United States
- Penn State Cancer Institute at Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
- Ccop - St. Vincent Hospital Cancer Center, Green Bay
Green Bay, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2000
- Primary completion
- 31 Mar 2006
- Completion
- —
- Last update posted
- 5 Feb 2009
- Registered enrollment
- —
- Registry id
- NCT00005966
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.